TRDMT1 and leukemia: demonstrated that m5C methyltransferases such as NSUN3 and DNMT2 can sensitise leukaemia cells to 5‐azacytidine, whereas resistant leukaemia cell lines and primary AML samples have been shown to have higher expression of NSUN1 instead.145